Armata Pharmaceuticals (ARMP) Share-based Compensation Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 0.18% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.66% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 23.70% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 37.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.64% |
| Dec 31, 2025 | 78.53% |
| Sep 30, 2025 | -7.16% |
| Jun 30, 2025 | -56.93% |
| Mar 31, 2025 | 46.25% |
| Dec 31, 2024 | 83.42% |
| Sep 30, 2024 | 279.62% |
| Jun 30, 2024 | 411.49% |
| Mar 31, 2024 | -37.69% |
| Dec 31, 2023 | -76.38% |
| Sep 30, 2023 | -144.09% |
| Jun 30, 2023 | -72.50% |
| Mar 31, 2023 | 73.83% |
| Dec 31, 2022 | 23.04% |
| Sep 30, 2022 | 80.38% |
| Jun 30, 2022 | 4.63% |
| Mar 31, 2022 | -41.45% |
| Dec 31, 2021 | -22.97% |
| Sep 30, 2021 | -29.26% |
| Jun 30, 2021 | 0.11% |
| Mar 31, 2021 | -19.35% |
| Dec 31, 2020 | -17.59% |
| Sep 30, 2020 | -73.46% |
| Jun 30, 2020 | 25.14% |
| Mar 31, 2020 | 954.55% |
| Dec 31, 2019 | 104,700.00% |
| Sep 30, 2019 | 31,125.00% |
| Jun 30, 2019 | 5,469.23% |
| Mar 31, 2019 | -18.85% |
| Dec 31, 2018 | -100.76% |
| Sep 30, 2018 | -91.84% |
| Jun 30, 2018 | -95.65% |
| Mar 31, 2018 | -28.65% |
| Dec 31, 2017 | -55.56% |
| Sep 30, 2017 | -70.66% |
| Jun 30, 2017 | -45.44% |
| Mar 31, 2017 | -79.04% |
| Dec 31, 2016 | 29.13% |
| Sep 30, 2016 | 124.16% |
| Jun 30, 2016 | 953.85% |